European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
复制标题
DOI:
10.1007/s12529-012-9242-5
复制
发表时间:
2012-12-01
影响因子:
2.7
通讯作者:
Zannad, Faiez
中科院分区:
文献类型:
--
作者:
Perk, Joep;De Backer, Guy;Zannad, Faiez
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has fallen considerably over recent decades in many European countries. It is estimated that> 80% of all CVD mortality now occurs in developing countries.CVD causes mass disability: within the coming decades the disability-adjusted life years (DALYs) estimate is expected to rise from a loss of 85 million DALYs in 1990 to a loss of $150 million DALYs globally in 2020, thereby remaining the leading somatic cause of loss of productivity. 1 CVD is strongly connected to lifestyle, especially the use of tobacco, unhealthy diet habits, physical inactivity, and psychosocial stress. 2 The World Health Organization (WHO) has stated that over three-quarters of all CVD mortality may be prevented with adequate changes in lifestyle. CVD prevention, remaining a major challenge for the general population, politicians, and healthcare workers alike, is defined as a co-ordinated set of actions, at public and individual level, aimed at eradicating, eliminating, or minimizing the impact of CVDs and their related disability. The bases of prevention are rooted in cardiovascular epidemiology and evidencebased medicine. 3